CD158e1 Antibody [DX9] (PE)
Product Specifications
Background
CD158e1 is a 70 kDa transmembrane glycoprotein and a killer cell immunoglobulin (Ig) -like receptor (KIR) that is expressed on a subset of natural killer cells and T cells. The monoclonal antibody DX9 is expressed on a subset of CD3-, CD56+ NK cells isolated from peripheral blood at varying levels (<0.1% to 61%) among individuals but not on thymocytes, B lymphocytes, granulocytes, or monocytes. Interactions with CD158e1 and certain MHC HLA-B antigens on a target cell inhibits cytotoxicity, possibly preventing target cell lysis and death. KIR and MHC class I interactions may regulate NK and T cell response to antigen stimulation.
NCBI Gene ID
3811
Swiss Prot
P43629
Accession Number
P43629
Host
Mouse
Reactivity
Human, Baboon
Immunogen
Human NK clone VL186-1 (CD3-, CD16+, CD56+)
Clonality
Monoclonal
Clone
[DX9]
Conjugation
PE
Type
Primary Antibodies
Field of Research
Immunology
Concentration
Batch dependent
Buffer
Supplied in PBS/NaN3 and a stabilizing agent
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store vial at 2-8˚ C
Fragment
IgG1
Specificity
CD158e1
Applications Notes
CD158e1 Antibody [DX9] for use in flow cytometry assays.
Symbol
KIR3DL1
NCBI Official Name
Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
NCBI Organism
Homo sapiens
Other Product Names
NKB1, p70, KIR, 3DL1, KIR3DL1, KIR3D, NKAT3
Tested Applications
Flow
Physical Properties
Liquid
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
